Literature DB >> 28500195

Glucagonlike peptide 1 analogs in diabetes care.

Adrienne J Lindblad1, Scott Garrison2, G Michael Allan3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28500195      PMCID: PMC5429054     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  8 in total

1.  Has pancreatic damage from glucagon suppressing diabetes drugs been underplayed?

Authors:  Deborah Cohen
Journal:  BMJ       Date:  2013-06-07

2.  Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Authors:  Steven P Marso; Stephen C Bain; Agostino Consoli; Freddy G Eliaschewitz; Esteban Jódar; Lawrence A Leiter; Ildiko Lingvay; Julio Rosenstock; Jochen Seufert; Mark L Warren; Vincent Woo; Oluf Hansen; Anders G Holst; Jonas Pettersson; Tina Vilsbøll
Journal:  N Engl J Med       Date:  2016-09-15       Impact factor: 91.245

3.  Pancreatic safety of incretin-based drugs--FDA and EMA assessment.

Authors:  Amy G Egan; Eberhard Blind; Kristina Dunder; Pieter A de Graeff; B Timothy Hummer; Todd Bourcier; Curtis Rosebraugh
Journal:  N Engl J Med       Date:  2014-02-27       Impact factor: 91.245

4.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; Christoph Wanner; John M Lachin; David Fitchett; Erich Bluhmki; Stefan Hantel; Michaela Mattheus; Theresa Devins; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

5.  A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.

Authors:  Carlos Alves; Francisco Batel-Marques; Ana F Macedo
Journal:  Diabetes Res Clin Pract       Date:  2012-09-23       Impact factor: 5.602

6.  Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome.

Authors:  Marc A Pfeffer; Brian Claggett; Rafael Diaz; Kenneth Dickstein; Hertzel C Gerstein; Lars V Køber; Francesca C Lawson; Lin Ping; Xiaodan Wei; Eldrin F Lewis; Aldo P Maggioni; John J V McMurray; Jeffrey L Probstfield; Matthew C Riddle; Scott D Solomon; Jean-Claude Tardif
Journal:  N Engl J Med       Date:  2015-12-03       Impact factor: 91.245

7.  Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Authors:  Steven P Marso; Gilbert H Daniels; Kirstine Brown-Frandsen; Peter Kristensen; Johannes F E Mann; Michael A Nauck; Steven E Nissen; Stuart Pocock; Neil R Poulter; Lasse S Ravn; William M Steinberg; Mette Stockner; Bernard Zinman; Richard M Bergenstal; John B Buse
Journal:  N Engl J Med       Date:  2016-06-13       Impact factor: 176.079

8.  Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials.

Authors:  Han Chen; Xiaoying Zhou; Tao Chen; Bingtuan Liu; Wujuan Jin; Huiyuan Gu; Tianyuan Hong; Guoxin Zhang
Journal:  Diabetes Ther       Date:  2016-09-21       Impact factor: 2.945

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.